Transplantation Pathology

  • Dean W. Chamberlain

Abstract

Serious consideration of lung transplantation as a treatment option for various forms of advanced pulmonary disease began with the first human lung transplant which was performed by Dr. James Hardy in 1963.1 However, there was little subsequent clinical success in this area until cyclosporin became available in 1981. Thirty-eight lung transplants had been carried out worldwide up to 1980, with only 2 patients surviving more than 1 month; the median survival was 8.5 days.2,3 Death usually occurred as a result of infection, complications in relation to the airway anastomosis, or rejection.

Keywords

Major Histocompatibility Complex Class Acute Rejection Lung Transplant Chronic Rejection Bronchiolitis Obliterans 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hardy JD, Webb WAS, Dalton ML, Walker GR. Lung homotransplantation in man. JAMA 1963; 186: 1065 1074.Google Scholar
  2. 2.
    Kamholz SL. Current perspectives in clinical and experimental single lung transplantation. Chest 1988; 94: 390–396.PubMedCrossRefGoogle Scholar
  3. 3.
    Nelems JMB, Rebuck AS, Cooper JD, Goldberg M, Halloran PF, Vellend H. Human lung transplantation. Chest 1980; 78: 569–573.PubMedCrossRefGoogle Scholar
  4. 4.
    Griffin BP, Hardesty RL, Bahnson HT. Powerful but limited immunosuppression for cardiac transplantation with cyclosporin and low-dose steroid. J Thorac Cardiovasc Surg 1984; 87: 35–42.Google Scholar
  5. 5.
    Reitz BA, Wallwork JL, Hunt SA, et al. Heart-lung transplantation: Successful therapy for patients with pulmonary vascular disease. New Engl J Med 1982; 306: 557–564.PubMedCrossRefGoogle Scholar
  6. 6.
    The Toronto Transplant Group. Unilateral lung transplantation for pulmonary fibrosis. N Engl J Med 1986; 314: 1140–1145.Google Scholar
  7. 7.
    Patterson GA, Cooper JD, Goldman B, et al. Technique of successful clinical double-lung transplantation. Ann Thorac Surg 1988; 45: 626–633.PubMedCrossRefGoogle Scholar
  8. 8.
    Atkinson JB. The pathology of heart-lung transplantation. Hum Pathol 1988; 19: 1367–1368.PubMedCrossRefGoogle Scholar
  9. 9.
    Hutter JA, Despins P, Higenbottam T, Stewart S, Wall-work J. Heart-lung transplantation: Better use of resources. Am J Med 1988; 85: 4–11.Google Scholar
  10. 10.
    Cooper JD. Current status of lung transplantation. Transplant Proc 1991; 23: 2107–2114.PubMedGoogle Scholar
  11. 11.
    Cooper JD, Pearson FG, Patterson GA, et al. Technique of successful lung transplantation in humans. J Thorac Cardiovasc Surg 1987; 93: 173–181.PubMedGoogle Scholar
  12. 12.
    Patterson GA, Todd TR, Cooper JD, Pearson FG, Winton TL, Mauer J. Airway complications after double lung transplantation. J Thorac Cardiovasc Surg 1990; 99: 14–21.PubMedGoogle Scholar
  13. 13.
    Dubois P, Choiniere L, Cooper JD. Bronchial omentopexy in canine lung allotransplantation. Ann Thorac Surg 1984; 38: 211–214.PubMedCrossRefGoogle Scholar
  14. 14.
    Paradis IL, Marrari M, Zeevi A, et al. HLA phenotype of lung lavage cells following heart-lung transplantation. Heart Transplant 1985; 4: 422–425.Google Scholar
  15. 15.
    Colvin RB. The pathogenesis of vascular rejection. Transplant Proc 1991; 23: 2052–2055.PubMedGoogle Scholar
  16. 16.
    Bach FH, Sachs DH. current concepts: Transplantation immunology. N Engl J Med 1987; 317: 489–492.PubMedCrossRefGoogle Scholar
  17. 17.
    Ettenger R, Ferstenberg LB. Basic immunology of transplantation. Perspect Pediatr Pathol. 1991; 14: 9–40.PubMedGoogle Scholar
  18. 18.
    Hall BM. Cells mediating allograft rejection. Transplantation 1991; 51: 1141–1151.PubMedCrossRefGoogle Scholar
  19. 19.
    Glanville AR, Tazelaar HD, Theodore J, et al. The distribution of MHC class I and II antigens on bronchial epithelium. Am Rev Respir Dis 1989; 139: 330–334.PubMedCrossRefGoogle Scholar
  20. 20.
    Lawrence EC. Diagnosis and management of lung allograft rejection. Clin Chest Med 1990; 11: 269–278.PubMedGoogle Scholar
  21. 21.
    Sleiman C, Groussard O, Mal H, et al. Clinical use of transbronchial biopsy in single-lung transplantation. Transplantation 1991; 51: 927–929.PubMedCrossRefGoogle Scholar
  22. 22.
    Veith FG, Hagstrom JWC. Alveolar manifestations of rejection: An important cause of the poor results with human lung transplantation. Ann Surg 1972; 175: 336348.Google Scholar
  23. 23.
    Prop J, Wildevuur CRH, Nienwenhuis P. Lung allograft rejection in the rat lung: Corresponding morphological rejection phases in various rat strain combinations. Transplantation 1985; 40: 132–136.Google Scholar
  24. 24.
    Prop J, Tazelaar HD, Billingham ME. Rejection of combined heart-lung transplants in rats. Am J Pathol 1987; 127: 97–105.PubMedGoogle Scholar
  25. 25.
    Scott WC, Haverich A, Billingham ME, Dawkins KD, Jamieson SW. Lethal rejection of the lung without significant cardiac rejection in primate heart-lung allotransplants. Heart Transplant 1984; 4: 33–39.Google Scholar
  26. 26.
    McGregor CGA, Baldwin JC, Jamieson SW, et al. Isolated pulmonary rejection after combined heart-lung transplantation. J Thorac Cardiovasc Surg 1985; 90: 623–630.PubMedGoogle Scholar
  27. 27.
    Hutter JA, Stewart S, Higenbottam T, Scott JP, Wall-work J. The characteristic histological changes associated with rejection in heart-lung transplant recipients. Transplant Proc 1989; 21: 435–436.Google Scholar
  28. 28.
    Starnes VA, Theodore J, Oyer PE, et al. Evaluation of heart-lung transplant recipients with prospective, serial transbronchial biopsies and pulmonary function studies. J Thorac Cardiovasc Surg 1989; 98: 683–690.PubMedGoogle Scholar
  29. 29.
    May RM, Cooper DKC, Dutoit ED, Reichart B. Cytoimmunologic monitoring after heart and heart-lung transplantation. J Heart Transplant 1990; 9: 133–135.PubMedGoogle Scholar
  30. 30.
    Hutter JA, Stewart S, Higenbottam T, Scott JP, Wall-work J. Histologic changes in heart-lung transplant recipients during rejection episodes and at routine biopsy. J Heart Transplant 1988; 7: 440–444.Google Scholar
  31. 31.
    Stewart S, Higenbottam TW, Hutter JA, Penketh ARL, Zebro TJ, Wallwork J. Histopathology of transbronchial biopsies in heart-lung transplantation. Transplant Proc 1988; 20: 764–766.Google Scholar
  32. 32.
    Higenbottam T, Stewart S, Wallwork J. Transbronchial lung biopsy to diagnose lung rejection and infection of heart-lung transplants. Transplant Proc 1988; 20: 767769.Google Scholar
  33. 33.
    Starnes VA, Theodore J, Oyer PE, et al. Pulmonary infiltrates after heart-lung transplantation: Evaluation by serial transbronchial biopsies. J Thorac Cardiovasc Surg 1989; 98: 945–950.PubMedGoogle Scholar
  34. 34.
    Higenbottam T, Stewart S, Penketh A, Wallwork J. Transbronchial lung biopsy for the diagnosis of rejection in heart-lung transplant patients. Transplantation 1988; 46: 532–539.PubMedCrossRefGoogle Scholar
  35. 35a.
    Clelland C, Higenbottam T, Otulana B, et al. Histologic prognostic indicators for lung allografts of heart-lung transplants. J Heart Transplant 1990; 9: 177–186.PubMedGoogle Scholar
  36. 35b.
    Scott JP, Fradet G, Smyth RL et al. Prospective study of transbronchial biopsies in the management of heart-lung and single lung transplant patients. J Heart Lung Transplant 1991; 10: 626–637.PubMedGoogle Scholar
  37. 36.
    Yousem SA, Berry GJ, Brunt EM, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. J Heart Transplant 1990; 9: 593–601.Google Scholar
  38. 37.
    Keenan RJ, Bruzzone P, Paradis IL, et al. Similarity of pulmonary rejection patterns among heart-lung and double-lung transplant recipients. Transplantation 1991; 51: 176–180.PubMedCrossRefGoogle Scholar
  39. 38.
    Cagle PT, Truong LD, Holland VA, Lawrence EC, Noon GP, Greenberg SD. Lung biopsy evaluation of acute rejection versus opportunistic infection in lung transplant patients. Transplantation 1989; 47: 713–715.PubMedCrossRefGoogle Scholar
  40. 39.
    Tazelaar HD. Perivascular inflammation in pulmonary infections: Implications for the diagnosis of lung rejection. J Heart Lung Transplant 1991; 10: 437–441.PubMedGoogle Scholar
  41. 40.
    Yousem SA, Randhawa P, Locker J, et al. Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: Primary presentation in the allograft. Hum Pathol 1989; 20: 361–369.PubMedCrossRefGoogle Scholar
  42. 41.
    Yousem SA, Paradis IL, Dauber JA. Large airway inflammation in heart-lung transplantation recipients-its significance and prognostic implications. Transplantation 1990; 49: 654–656.PubMedCrossRefGoogle Scholar
  43. 42.
    Hruban RH, Beschorner WE, Baumgartner WA, et al. Diagnosis of lung allograft rejection by bronchial intraepithelial Leu-7 positive T lymphocytes. J Thorac Cardiovasc Surg 1988; 96: 939–946.PubMedGoogle Scholar
  44. 43.
    Yousem SA, Paradis IL, Dauber JH, et al. Pulmonary arteriosclerosis in long-term human heart-lung transplant recipients. Transplantation 1989; 47: 564–569.PubMedCrossRefGoogle Scholar
  45. 44.
    Scott JP, Higenbottam TW, Clelland C, et al. The natural history of obliterative bronchiolitis and occlusive vascular disease of patients following heart-lung transplantation. Transplant Proc 1989; 21: 2592–2593.PubMedGoogle Scholar
  46. 45.
    Hruban RH, Beschorner WE, Hutchins GM. Lymphocytic bronchitis and lung allograft rejection. Transplantation 1990; 50: 723.PubMedCrossRefGoogle Scholar
  47. 46.
    Burke CM, Theodore J, Dawkins KD, et al. Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation. Chest 1984; 86: 824–829.PubMedCrossRefGoogle Scholar
  48. 47.
    Burke CM, Baldwin JC, Morris AJ, et al. Twenty-eight cases of heart-lung transplantation. Lancet 1986;i:517519.Google Scholar
  49. 48.
    Burke CM, Glanville AR, Theodore J, Robin ED. Lung immunogenicity, rejection and obliterative bronchiolitis. Chest 1987; 92: 547–549.PubMedCrossRefGoogle Scholar
  50. 49.
    Hruban RH, Beschorner WE, Baumgartner WA, et al. Evidence that the expression of class II MHC antigens is not diagnostic of lung allograft rejection. Transplantation 1989; 48: 529–530.PubMedCrossRefGoogle Scholar
  51. 50.
    Griffith BP, Paradis IL, Zeevi A, et al. Immunologically mediated disease of the airways after pulmonary transplantation. Ann Surg 1988; 208: 371–378.PubMedCrossRefGoogle Scholar
  52. 51.
    Gryzan S, Paradis IL, Zeevi A, et al. Unexpectedly high incidence of pneumocystis carinii infection after lung-heart transplantation. Am Rev Respir Dis 1988; 137: 1268–1274.PubMedCrossRefGoogle Scholar
  53. 52.
    Taylor PM, Rose ML, Yacoub MH. Expression of MHC antigen in normal human lungs and transplanted lungs with obliterative bronchiolitis. Transplantation 1989; 48: 506–510.PubMedCrossRefGoogle Scholar
  54. 53.
    Yousem SA, Dauber JA, Keenan R, Paradis IL, Zeevi A, Griffith BP. Does histologic acute rejection in lung allografts predict the development of bronchiolitis obliterans. Transplantation 1991; 52: 306–309.PubMedCrossRefGoogle Scholar
  55. 54a.
    Keenan RJ, Lega ME, Dummer JS, et al. Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation 1991; 51: 433–438.PubMedCrossRefGoogle Scholar
  56. 54b.
    Reinsmoen NL, Bolman RM, Savik K, Butters K, Hertz M. Differentiation of class I and classll-directed donor-specific alloreactivity in bronchoalveolar lavage lymphocytes from lung transplant recipients. Transplantation 1992; 53: 181–189.Google Scholar
  57. 55.
    Dauber JH, Paradis IL, Dummer JS. Infectious complications in pulmonary allograft recipients. Clin Chest Med 1990; 11: 291–308.PubMedGoogle Scholar
  58. 56.
    Armitage JM, Kormos RL, Stuart RS. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: Ten years of cyclosporin-based immunosuppression. J Heart Lung Transplant 1991; 10: 877–887.PubMedGoogle Scholar
  59. 57.
    deHoyos A, Ramirez J, Patterson A, Mauer J. Infectious complications after double lung transplantation for cystic fibrosis. Am Rev Respir Dis 1991; 143: A455.Google Scholar
  60. 58.
    Ognibene FP, Shelhamer J, Gill V, et al. The diagnosis of pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome using subsegmental bronchoalveolar lavage. Am Rev Respir Dis 1984; 129: 929–932.PubMedGoogle Scholar
  61. 59.
    Golden JA, Hollander H, Stulbarg MS, Gamsu G. Bronchoalveolar lavage as the exclusive diagnostic modality for pneumocystis carinii pneumonia. Chest 1986; 90: 1822.CrossRefGoogle Scholar
  62. 60.
    Wreghitt, T. Cytomegalovirus infections in heart and heart-lung transplant recipients. J Antimicrob Chemother 1989; 23 (suppl E): 49–60.PubMedCrossRefGoogle Scholar
  63. 61.
    Smith CB. Cytomegalovirus pneumonia. State of the Art. Chest 1989; 95 (suppl): 1825–1875.Google Scholar
  64. 62.
    Sissons JGP, Borysiewicz LK. Human cytomegalovirus infection. Thorax 1989; 44: 241–246.PubMedCrossRefGoogle Scholar
  65. 63.
    Smyth RL, Sinclair J, Scott JP et al. Infection and reactivation with cytomegalovirus strains in lung transplant recipients. Transplantation 1991; 52: 480–482.PubMedCrossRefGoogle Scholar
  66. 64.
    Paradis IL, Grgurich WF, Dummer JS, Dekker A, Dauber JH. Rapid detection of cytomegalovirus pneumonia from lung lavage cells. Am Rev Respir Dis 1988; 138: 697–702.PubMedCrossRefGoogle Scholar
  67. 65.
    Crawford SW, Bowden RA, Hackman RC, et al. Rapid detection of cytomegalovirus pulmonary infection by bronchoalveolar lavage and centrifugation culture. Ann Intern Med 1988; 108: 180–185.PubMedCrossRefGoogle Scholar
  68. 66.
    Kahn FW, Jones JM, England DM. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergilloses. Am J Clin Pathol 1986; 86: 518–523.PubMedGoogle Scholar
  69. 67.
    Paull DE, Keagy BA, Entwistle T, Wilcox BR. Effect of superoxide dismutase and catalase infusion at reflow on cardiopulmonary function after lung ischaemia in dogs breathing room air. Curr Surg 1988; 45: 292–294.PubMedGoogle Scholar
  70. 68.
    Jansen NJG, van Oeveren W, Broek LVD. Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991; 102: 515–525.PubMedGoogle Scholar
  71. 69.
    Lima O, Goldberg M, Peters WJ, Ayabe H, Townsend E, Cooper JD. Bronchial omentopexy in canine lung transplantation. J Thorac Cardiovasc Surg 1982; 83: 418–421.PubMedGoogle Scholar
  72. 70.
    Schafers, H, Haydock DA, Cooper JD. The prevalence and management of bronchial anastomotic complications in lung transplantation. J Thorac Cardiovasc Surg 1991; 101: 1044–1052.PubMedGoogle Scholar
  73. 71.
    Yousem SA, Dauber J H, Griffith BP. Bronchial cartilage alterations in lung transplantation. Chest 1990; 98: 1121–1124.PubMedCrossRefGoogle Scholar
  74. 72.
    Tazelaar HD, Yousem SA. The pathology of combined heart-lung transplantation: an autopsy study. Hum Pathol 1988; 19: 1403–1416.PubMedCrossRefGoogle Scholar
  75. 73a.
    Nalesnik MA, Jaffe, R, Starzl TE, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporin A-prednisone immunosuppression. Am J Pathol 1988; 133: 173–192.PubMedGoogle Scholar
  76. 73b.
    Berg LC, Copenhaver CM, Morrison VA. B-cell lymphoproliferative disorders in solid-organ transplant patients: detection of Epstein-Barr virus by in situ hybridization. Hum Pathol 1992; 23: 159–163.PubMedCrossRefGoogle Scholar
  77. 74.
    Gilman MJ, Wang KP. Transbronchial lung biopsy in sarcoidosis-an approach to determine the optimal number of biopsies. Am Rev Respir Dis 1980; 122: 72 1724.Google Scholar
  78. 75.
    Reynolds HY. Bronchoalveolar lavage. Am Rev Respir Dis 1987; 135: 250–263.PubMedGoogle Scholar
  79. 76.
    Chamberlain DW, Braude AC, Rebuck AS. A critical evaluation of bronchoalveolar lavage: Criteria for identifying unsatisfactory specimens. Acta Cytol 1987; 31: 599–605.PubMedGoogle Scholar
  80. 77.
    Nishio JN, Lynch JP. Fiberoptic bronchoscopy in the immunocompromised host: The significance of a “nonspecific” transbronchial biopsy. Am Rev Respir Dis 1980; 121: 307–312.PubMedGoogle Scholar
  81. 78.
    Katzenstein AA, Askin FB. Interpretation and significance of pathologic findings in transbronchial lung biopsy. Am J Surg Pathol 1980; 4: 223–234.PubMedCrossRefGoogle Scholar
  82. 79.
    Jenkins R, Myerowitz RL, Kavic T, Slasky S. Diagnostic yield of transbronchial biopsies. Am J Clin Pathol 1979; 72: 926–930.PubMedGoogle Scholar
  83. 80a.
    Yousem 5A, Paradis IL, Dauber JH, Griffith BP. Efficacy of transbronchial lung biopsy in the diagnosis of bronchiolitis obliterans in heart-lung transplant recipients. Transplantation 1989; 47: 893–895.Google Scholar
  84. 80b.
    Abernathy EC, Hruban RH, Baumgartner WA, Reitz BA, Hutchins GM. The two forms of bronchiolitis obliterans in heart-lung transplant recipients. Hum Pathol 1991; 22: 1102–1110.PubMedCrossRefGoogle Scholar
  85. 81.
    Gryzan S, Paradis IL, Hardesty RL, Griffith BP, Dauber JH. Bronchoalveolar lavage in heart-lung transplantation. Heart Transplant 1985; 4: 414–416.Google Scholar
  86. 82.
    Shennib H, Nguyen D. Bronchoalveolar lavage in lung transplantation. Ann Thorac Surg 1991; 51: 335–340.PubMedCrossRefGoogle Scholar
  87. 83.
    Rabinowich H, Zeevi A, Paradis IL, et al. Proliferative responses of bronchoalveolar lavage lymphocytes from heart-lung transplant patients. Transplantation 1990; 49: 115–121.PubMedCrossRefGoogle Scholar
  88. 84.
    Zeevi A, Rabinbwich H, Yousem SA, et al. Presence of donor-specific alloreactivity in histologically normal lung allografts is predictive of subsequent bronchiolitis obliterans. Transplant Proc 1991; 23: 1128–1129.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Dean W. Chamberlain

There are no affiliations available

Personalised recommendations